BackOsmotica Pharmaceuticals Plc Overview

Osmotica Pharmaceuticals Plc Total Current Liabilities

Track Osmotica Pharmaceuticals Plc's total current liabilities ($68M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$68.39M
268.59% YoYΔ $49.84M vs prior year quarter

Peer average

Loading

Osmotica Pharmaceuticals Plc Total Current Liabilities History

Loading

Osmotica Pharmaceuticals Plc vs. peers: Total Current Liabilities Comparison

Loading

Osmotica Pharmaceuticals Plc Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Osmotica Pharmaceuticals Plc (OSMT) FAQ

Osmotica Pharmaceuticals Plc (OSMT) currently reports a total current liabilities of $68M as of June 2023. That compares with $19M in the prior-year period — up 268.6% year over year. Use the charts on this page to explore Osmotica Pharmaceuticals Plc's total current liabilities history and peer comparisons.

Osmotica Pharmaceuticals Plc's total current liabilities increased from $19M to $68M — a 268.6% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Osmotica Pharmaceuticals Plc reported $68M in total current liabilities as of June 2023. That compares with $19M in the prior-year period — up 268.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $68M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Osmotica Pharmaceuticals Plc, and consider following OSMT for alerts when major investors trade the stock.

Osmotica Pharmaceuticals Plc is classified in the Healthcare sector. On total current liabilities, it currently shows $68M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OSMT with unrelated industries.